Battery explantation after sacral neuromodulation in the medicare population
Authors:
- Anne P. CameronACAnne P. Cameron
- The Urologic Diseases In America ProjectTPThe Urologic Diseases In America Project
- 27 July 2012
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 32 (3) , 238-241
Abstract
Aims: To determine sacral neuromodulation battery life and the patient and provider risk factors for early explantation in a population‐based sample.Methods: A 5% sample of Medicare beneficiaries from 1997 to 2007 served as the data source. All patients who had a sacral neuromodulation device implanted in that time period were included. Variables included in a multivariate analysis of risk factors for removal included gender, age, race, diagnosis, type of test phase, provider specialty, and volume. The number of device reprogramming events was also recorded in this time period.Results: Mean follow‐up was 60.5 months. Patients on average had 2.15 reprogramming episodes in their first year, with that number decreasing over subsequent years. Out of the 558 batteries implanted 63 (11.3%) were explanted. Of the 19 implanted individuals who carried the diagnosis of interstitial cystitis (IC), 11 (57.9%) had the battery removed. This was the only variable that predicted early removal, with an odds ratio of explantation of 10.5 (95% CI: 3.9–28.4).Conclusion: Very few sacral neuromodulation batteries, once implanted, are removed prematurely. Patients with IC, however, are at very high risk of requiring premature battery removal. Neurourol. Urodynam. 32: 238–241, 2013.Keywords
Funding Information
- NIDDK (N01 DK012460)
This publication has 13 references indexed in Scilit:
- National Trends in the Usage and Success of Sacral Nerve Test StimulationJournal of Urology, 2011
- The long‐term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centreBJU International, 2010
- Long-Term Outcomes of Urgency-Frequency Syndrome Due to Painful Bladder Syndrome Treated With Sacral Neuromodulation and Analysis of FailuresJournal of Urology, 2010
- Incidence and Predictors of Complications With Sacral NeuromodulationUrology, 2009
- A prospective, single‐blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitisBJU International, 2007
- Sacral nerve stimulation for voiding dysfunction: One institution's 11‐year experienceNeurourology and Urodynamics, 2006
- Complications and troubleshooting of two-stage sacral neuromodulation therapy: A single-institution experienceUrology, 2006
- Long Term Results of Neuromodulation by Sacral Nerve Stimulation for Lower Urinary Tract Symptoms: A Retrospective Single Center StudyEuropean Urology, 2006
- Sacral Neuromodulation for the Symptomatic Treatment of Refractory Interstitial Cystitis: A Prospective StudyJournal of Urology, 2003
- Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retentionUrology, 2000